Elsevier

Progress in Cardiovascular Diseases

Volume 40, Issue 2, September–October 1997, Pages 107-116
Progress in Cardiovascular Diseases

The biology of restenosis

https://doi.org/10.1016/S0033-0620(97)80003-5Get rights and content

Recent studies have allowed a better understanding of the biology of restenosis. Neointimal thickening-also referred to as neointimal hyperplasia-occurs in response to experimental arterial injury. This process involves different steps which include smooth muscle cell activation, proliferation, and migration, and the production of extracellular matrix. Neointimal thickening has been identified as one of the mechanisms of restenosis after balloon angioplasty in humans. The factors which control neointimal thickening include growth factors, hormonal factors, and mechanical factors. Delinquent reendothelialization has been shown to have a permissive impact on smooth muscle cell proliferation. In addition to neointimal thickening, arterial remodeling also plays a major role in restenosis. Studies performed on animals and in human subjects have established the potential for “constrictive remodeling” to reduce the vessel lumen after angioplasty. Restenosis thus appears as a multifactorial entity that may be addressed in the future by a combined mechanical and pharmacological approach.

References (122)

  • LiuMW et al.

    Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

    Circulation

    (1989)
  • BautersC et al.

    Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site: A quantitative angiographic study in consecutive patients undergoing a third angioplasty for a second restenosis

    Circulation

    (1993)
  • HerrmanJPR et al.

    Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the holy grail? (Part I)

    Drugs

    (1993)
  • FranklinSM et al.

    Pharmacologic prevention of restenosis after coronary angioplasty: Review of the randomized clinical trials

    Coronary Artery Dis

    (1993)
  • GrinesCL et al.

    A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction

    N Engl J Med

    (1993)
  • PepineCJ et al.

    A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty

    Circulation

    (1990)
  • BautersC et al.

    Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty?

    Eur Heart J

    (1992)
  • MianoJM et al.

    Localization of fos and jun proteins in rat aortic smooth muscle cells after vascular injury

    Am J Pathol

    (1993)
  • SimonsM et al.

    Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo

    Nature

    (1992)
  • BennettMR et al.

    Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

    J Clin Invest

    (1994)
  • ThybergJ et al.

    Regulation of differentiated properties and proliferation of arterial smooth muscle cells

    Arteriosclerosis

    (1990)
  • SchwartzSM et al.

    Replication of smooth muscle cells in vascular disease

    Circ Res

    (1986)
  • RubbiaL et al.

    Phénotype des cellules musculaires lisses artérielles et athérosclérose

    Med/Sciences

    (1989)
  • MajeskyMW et al.

    Heparin regulates smooth muscle S phase entry in the injured-rat carotid artery

    Circ Res

    (1987)
  • ClowesAW et al.

    Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin

    Lab Invest

    (1985)
  • CasscellsW

    Migration of smooth muscle and endothelial cells. Critical events in restenosis

    Circulation

    (1992)
  • ClowesAW et al.

    Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium

    Lab Invest

    (1983)
  • ClowesAW et al.

    Arterial smooth muscle cells in vivo: Relationship between actin isoform expression and mitogenesis and their modulation by heparin

    J Cell Biol

    (1988)
  • LindnerV et al.

    Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries

    J Clin Invest

    (1990)
  • ClowesAW et al.

    A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat

    Lab Invest

    (1978)
  • ReidyMA et al.

    Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit

    Lab Invest

    (1983)
  • LindnerV et al.

    Regrowth of arterial endothelium. Denudation with minimal trauma leads to complete endothelial cell regrowth

    Lab Invest

    (1989)
  • WeidingerFF et al.

    Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery

    Circulation

    (1990)
  • HaudenschildCC et al.

    Endothelial regeneration. II. Restitution of endothelial continuity

    Lab Invest

    (1979)
  • ReidyMA et al.

    Inhibition of endothelial cell regrowth. Cessation of aortic endothelial cell replication after balloon catheter denudation

    Arteriosclerosis

    (1982)
  • SpagnoliLG et al.

    Morphometric analysis of gap junctions in regenerating arterial endothelium

    Lab Invest

    (1982)
  • HamonM et al.

    Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury

    Circulation

    (1994)
  • ShimokawaH et al.

    Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin

    Circ Res

    (1987)
  • SaroyanRM et al.

    Differential recovery of prostacyclin and endothelium-derived relaxing factor after vascular injury

    Am J Physiol

    (1992)
  • StemermanMB et al.

    The pattern of reendothelialization and intimal thickening

    Am J Pathol

    (1977)
  • FishmanJA et al.

    Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening

    Lab Invest

    (1975)
  • ReidyMA

    Endothelial regeneration. VII. Interaction of smooth muscle cells with endothelial regrowth

    Lab Invest

    (1988)
  • Scott-BurdenT et al.

    The endothelium as a regulator of vascular smooth muscle proliferation

    Circulation

    (1993)
  • GargUC et al.

    Nitric oxide-generating vasodilators and 8-bromo-cyclic-guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

    J Clin Invest

    (1989)
  • DoornekampFNG et al.

    Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in rabbit carotid artery

    J Vasc Res

    (1996)
  • PalmerRMJ et al.

    Vascular endothelial cells synthetize nitric oxide from L-arginine

    Nature

    (1988)
  • MoncadaS et al.

    The l-arginine-nitric oxide pathway

    N Engl J Med

    (1993)
  • TakeshitaS et al.

    Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency

    Am J Pathol

    (1995)
  • von der LeyenHE et al.

    Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cellnitric oxide synthase gene

  • TaguchiJ et al.

    L-arginine inhibits neointimal formation following balloon injury

    Life Sci

    (1993)
  • Cited by (193)

    • Evaluation of Venous Stenosis Angioplasty in a Murine Arteriovenous Fistula Model

      2019, Journal of Vascular and Interventional Radiology
    • LIM and cysteine-rich domains 1 is required for thrombininduced smooth muscle cell proliferation and promotes atherogenesis

      2018, Journal of Biological Chemistry
      Citation Excerpt :

      Restenosis, characterized by arterial wall thickening and decreased arterial lumen space, occurs as a response to vascular injury (1, 2).

    • Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation

      2016, Cellular Signalling
      Citation Excerpt :

      Because reactive oxygen species (ROS) are a risk factor for CVD pathologies, ROS-mediated oxidation of the sGC heme iron prevents NO binding and negatively impacts homeostatic cell signaling which has been found to promote aberrant ASM growth [5,6]. Additionally, current surgical strategies include balloon angioplasty and/or stent deployment which often fail due to vessel remodeling and neointimal development [7]. The current study was designed to investigate ability of pharmacologic heme-independent activation of endogenous sGC to prevent ASM cell migration as a key component of pathologic vascular growth.

    • Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis

      2016, Atherosclerosis
      Citation Excerpt :

      However, additional vascular cells may play a role in this proliferative process. Conventionally, resident intimal SMC proliferation plays a major role in restenosis [10]. SMCs include thin (α-actin positive) and thick (smooth muscle myosin heavy chain- SMMHC) filaments [11].

    View all citing articles on Scopus
    View full text